The Washington Report
June 14, 2023
Note to Subscribers
While we do our best to provide timely updates, it is possible that the information shared in the newsletter may change after our publication deadline.
Health
HHS Announces Prescription Drug Savings as Part of Inflation Reduction Act; Releases Report on Medicare Part B Drug Price Trends
On June 9, 2023, the Department of Health and Human Services (HHS) announced a list of 43 prescription drugs for which Medicare Part B beneficiaries’ coinsurances may be lower between July 1 through September 30, 2023, as part of the Inflation Reduction Act. On the same day, HHS also released a report (Medicare Part B Drugs: Trends in Spending and Utilization, 2008-2021), analyzing trends that have driven growth in spending for Medicare Part B drug coverage.
Please refer to the news release and corresponding resources for additional information.
The news release is available here.
The report, Medicare Part B Drugs: Trends in Spending and Utilization, 2008-2021, is available here.
Information about the 43 Part B drugs and biological products with lower coinsurance in the quarterly Average Sales Price public files is available here.
A Fact Sheet is available here.
If you elect to comment or engage with our content via third-party social media websites, you authorize Aon to have access to certain social media profile information. Please click here to learn more about information that may be collected when using these tools on Aon.com